đź“‹ FDA Reference

cordis encor pervenous atrial ventricular leads

Cordis

Summary: The Cordis Encor Pervenous Atrial Ventricular Leads are used for cardiac pacing in patients with heart rhythm disorders. They are primarily used by cardiologists in hospital settings.

FDA Clearance Information

Pathway 510K
Decision Date March 27, 1985
Product Code DTB
Device Class Class 3
Evidence 0 studies

The Cordis Encor Pervenous Atrial Ventricular Leads were cleared through the FDA 510k pathway on March 27, 1985. Manufactured by Cordis, this Class 3 device is used for cardiac pacing.

What It Is

The Cordis Encor Pervenous Atrial Ventricular Leads are medical devices designed for cardiac pacing. They are implanted into the heart to help regulate heart rhythms in patients with arrhythmias. These leads are inserted through the venous system and positioned in the atrium and ventricle to deliver electrical impulses that ensure proper heart function.

Clinical Applications

These leads are commonly used in patients with bradycardia or other arrhythmias that require pacing. Cardiologists typically implant these devices in a hospital or surgical setting. They are suitable for adult patients who need long-term pacing support, particularly those with conditions like sick sinus syndrome or heart block.

Indications for Use

The FDA indications suggest these leads are for patients who require cardiac pacing due to arrhythmias. They are specifically used in conditions where the heart's natural pacemaker is not functioning properly.

Practical Considerations

The leads come in various sizes to accommodate different patient anatomies. They are compatible with most pacemaker generators. Proper placement technique is crucial to ensure effective pacing and minimize complications.

Frequently Asked Questions

What is Cordis Encor Pervenous Atrial Ventricular Leads used for?

They are used for cardiac pacing in patients with heart rhythm disorders like bradycardia.

What specialties typically use this device?

Cardiologists typically use these leads in hospital or surgical settings.

What are the FDA-cleared indications?

They are indicated for patients requiring cardiac pacing due to arrhythmias such as bradycardia or heart block.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.